(Q35022795)

5 August 2017

1 reference

title

Current management of interstitial cystitis (English)

1 reference

5 August 2017

James Chivian Lukban

1

1 reference

5 August 2017

Kristene E Whitmore

series ordinal

2

1 reference

5 August 2017

Grannum R Sant

series ordinal

3

1 reference

5 August 2017

publication date

1 August 2002

1 reference

Urologic Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

29

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

649-660

1 reference

A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis).

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

A diagnostic in vitro urine assay for interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

The natural history of interstitial cystitis: a survey of 374 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Behavioral intervention for community-dwelling individuals with urinary incontinence

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Interstitial cystitis: successful management by increasing urinary voiding intervals

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Behavioral therapy for the treatment of refractory interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

1 reference

7 January 2021

Origin of pain in interstitial cystitis. Effect of ultrasound treatment on the concomitant levator ani spasm syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Rectal pain of extrarectal origin

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Evaluation and treatment of chronic intractable rectal pain--a frustrating endeavor

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Biofeedback is effective treatment for levator ani syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

The levator syndrome and its treatment with high-voltage electrogalvanic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Levator syndrome. A treatment that works

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Electrogalvanic stimulation in the treatment of levator syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Treatment of levator syndrome using high-voltage electrogalvanic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Electrogalvanic stimulation for levator syndrome: how effective is it in the long-term?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Bladder-Surface Glycosaminoglycans: An Efficient Mechanism of Environmental Adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Bladder surface glycosaminoglycans: an epithelial permeability barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Successful therapy of interstitial cystitis with pentosanpolysulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Safety and efficacy of up to 900 mg/day polysulfate sodium (elmiron) in patients with interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Mast cells in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Increased number of substance P positive nerve fibres in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Hydroxyzine inhibits neurogenic bladder mast cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Hydroxyzine therapy for interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Amitriptyline versus placebo in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Amitriptyline and chronic low-back pain. A randomized double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

DMSO: effect on bladder afferent neurons and nitric oxide release

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

A controlled study of dimethyl sulfoxide in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Prolongation of response to DMSO by heparin maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Interleukin-6 and interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Bacillus Calmette-Guérin immunotherapy for refractory interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Characterization and immunohistochemical localization of the glycoconjugates of the rabbit bladder mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Localization and quantity of hyaluronan in urogenital organs of male and female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Increased urinary hyaluronic acid and interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Principles of Sacral Nerve Stimulation (SNS) for the Treatment of Bladder and Urethral Sphincter Dysfunctions

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Studies of the latency of pelvic floor contraction during peripheral nerve evaluation show that the muscle response is reflexly mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Sacral nerve stimulation in patients with chronic intractable pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Substitution cystoplasty for intractable interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

The management of chronic interstitial cystitis by substitution cystoplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

Pelvic Pain Without Pelvic Organs

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900055-1

7 January 2021

10.1016/S0094-0143(02)00055-1

Identifiers

DOI

1 reference

5 August 2017

1 reference